Status:
COMPLETED
Improvement of Migraine Severity and Frequency With Migraineguard ™
Lead Sponsor:
Herbacure Natural
Conditions:
Migraine
Headache
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Numerous treatments have been recommended for the prevention of migraine. The purpose of this randomized double-blind placebo controlled trial was to assess the efficacy of MIGRAINEGUARD ™ supplement ...
Detailed Description
Our team will assess MIGRAINEGUARD ™ , a migraine prevention supplement marketed Herbacure Natural for individual suffering from multiple migraine attacks in one month . The purpose of this 7-months ,...
Eligibility Criteria
Inclusion
- Adult aged 18 to 65 years Female and Male
- Based on IHS criteria ,are diagnosed with migraine (criteria of the International Classification of Headaches Disorders)
- Individuals with minimum of 3 severe to extreme migraine attacks during the last 3 months .
- Generally in good health
Exclusion
- Individuals taking any preventive treatment for migraine
- Excessive usage of painkillers
- Cancer \& Head injury and trauma
- Any medical condition that may impact the validity of collected information
- Previous usage of Botox within 6 months of study
- Last week usage of triptans
Key Trial Info
Start Date :
April 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 25 2020
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04759040
Start Date
April 1 2020
End Date
November 25 2020
Last Update
March 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Herbacure Natural
Burnaby, British Columbia, Canada, V3J 1N3